These tests could help healthcare professionals identify individuals who have developed an adaptive immune response to SARS-CoV-2 — the coronavirus that causes COVID-19.Â
The generic drug, once used to treat a myriad of other diseases, was unleashed against coronavirus in an attempt to wield against the virus ravaging the globe.Â
In an ever-changing world of new regulations, partnerships, and strategy, one healthcare leader believes the U.S. market will be forever marked by COVID-19.
Earlier this month, the U.S. Food and Drug Administration (FDA) unveiled their steps to focus on not only preventing COVID-19, but treating the disease as well.
The U.S. Food and Drug Administration clarified its rules around personal protective equipment (PPE) and its Emergency Use Authorizations regarding COVID-19.